Potentiation of the anticancer effects of everolimus using a dual mTORC1/2 inhibitor in hepatocellular carcinoma cells

There is lots of evidence to support the critical involvement of mTOR signaling in the carcinogenesis of hepatocellular carcinoma (HCC). However, it has not been determined how the roles of individual mTORC1 and mTORC2 inhibitors played in the HCC therapeutics. We thus compared the effects of everol...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Kim, Jong-Ok, Kim, Kee-Hwan, Song, In Sang, Cheon, Kwang-Sik, Kim, Ok-Hee, Lee, Sang Chul, Lee, Sang Kuon, Kim, Say-June
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5356853/
https://ncbi.nlm.nih.gov/pubmed/27935857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13808
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares